dapaveldactin10mg28tab new

Dapaveldactin is a combination medication used in the management of type 2 diabetes mellitus. It combines Dapagliflozin, an SGLT2 inhibitor that helps the kidneys remove glucose from the bloodstream through urine, and Vildagliptin, a DPP-4 inhibitor that increases insulin production and decreases glucose production by the liver. This dual-action approach helps patients achieve better glycemic control when diet and exercise alone are insufficient. It is intended for use in adult patients to maintain stable blood sugar levels and reduce the risk of hyperglycemia-related complications.